CalciMedica, Inc.
CalciMedica, Inc. (CALC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CALC · as of Jun 9, 2026
Key Statistics
Explore CalciMedica, Inc. Data
calc stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 66.7%
The CALC analyst consensus is Buy, based on ratings from 3 Wall Street analysts over the past 3 months. The average 12-month price target is $266.00, representing +27666.18% upside from the current price of $0.96.
Competitors & Peers
calc competitorsCALC
ATNM
ELUT
LTRN
LVTX
MAIAStock Performance
Full HistoryAbout CalciMedica, Inc.
CalciMedica, Inc. a clinical-stage biotechnology company headquartered in La Jolla, California, is focused on creating treatments for life-threatening inflammatory diseases that currently lack adequa…
what is calcimedica, inc. · calc stock overview · calcimedica, inc. company profile · who is calcimedica, inc. ceo · calc NASDAQ · calcimedica, inc. headquarters · calcimedica, inc. business segments
About Stock Overview & Key Data
CalciMedica, Inc. (CALC) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 14, 2023. As of the latest trading session, CALC stock price is $0.96, with a market capitalization of $15.1M. The stock has returned -46.48% over the past 12 months and -85.46% year-to-date.
According to 3 Wall Street analysts, the consensus rating for CalciMedica, Inc. stock is Buy, with an average 12-month price target of $266.00. In fiscal year 2025, CalciMedica, Inc. reported revenue of — and net income of -$29.6M. For detailed data — including CalciMedica, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, CalciMedica, Inc. (CALC) stock price is $0.96. The stock is traded on NASDAQ under the ticker symbol CALC. The 52-week range is $0.46 – $7.20.